Canada Life’s Integra LifeSciences IART Stock Holding History

Canada Life’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$560K	Hold	59,435	–	–	﹤0.01%	1483
2025 Q4	$737K	Hold	59,435	–	–	﹤0.01%	1442
2025 Q3	$809K	Hold	59,435	–	–	﹤0.01%	1493
2025 Q2	$729K	Sell	59,435 -20,018	-25%	-$291K	﹤0.01%	1516
2025 Q1	$1.75M	Sell	79,453 -6,590	-8%	-$155K	﹤0.01%	1255
2024 Q4	$1.95M	Sell	86,043 -854	-1%	-$18.6K	﹤0.01%	1277
2024 Q3	$1.58M	Buy	86,897 +2,476	+3%	+$57.4K	﹤0.01%	1381
2024 Q2	$2.46M	Buy	84,421 +34,659	+70%	+$1.03M	﹤0.01%	1182
2024 Q1	$1.76M	Buy	49,762 +551	+1%	+$22K	﹤0.01%	1302
2023 Q4	$2.14M	Sell	49,211 -3,408	-6%	-$134K	﹤0.01%	1216
2023 Q3	$2.01M	Buy	52,619 +3,900	+8%	+$164K	﹤0.01%	1203
2023 Q2	$2.01M	Sell	48,719 -7,966	-14%	-$383K	﹤0.01%	1201
2023 Q1	$3.25M	Buy	56,685 +2,195	+4%	+$124K	0.01%	981
2022 Q4	$3.06M	Buy	54,490 +7,934	+17%	+$404K	0.01%	1006
2022 Q3	$1.97M	Buy	46,556 +2,115	+5%	+$108K	0.01%	1189
2022 Q2	$2.4M	Buy	44,441 +4,429	+11%	+$266K	0.01%	1067
2022 Q1	$2.64M	Buy	40,012 +2,969	+8%	+$195K	0.01%	1063
2021 Q4	$2.48M	Buy	37,043 +2,642	+8%	+$179K	0.01%	1081
2021 Q3	$2.37M	Buy	34,401 +6,804	+25%	+$481K	0.01%	1076
2021 Q2	$1.88M	Buy	27,597 +270	+1%	+$19.1K	﹤0.01%	1197
2021 Q1	$1.89M	Sell	27,327 -2,376	-8%	-$161K	﹤0.01%	1197
2020 Q4	$1.93M	Sell	29,703 -4,163	-12%	-$224K	﹤0.01%	1159
2020 Q3	$1.6M	Sell	33,866 -1,338	-4%	-$63.6K	﹤0.01%	1180
2020 Q2	$1.65M	Sell	35,204 -1,834	-5%	-$90.2K	﹤0.01%	1173
2020 Q1	$1.66M	Buy	37,038 +2,252	+6%	+$118K	﹤0.01%	1043
2019 Q4	$2.01M	Buy	+34,786	New	+$2.07M	﹤0.01%	1132
2019 Q3	–	Sell	-42,377	Closed	-$2.37M	–	1658
2019 Q2	$2.37M	Sell	42,377 -780	-2%	-$40.2K	0.01%	1089
2019 Q1	$2.4M	Sell	43,157 -798	-2%	-$40.6K	0.01%	943
2018 Q4	$1.84M	Buy	43,955 +3,225	+8%	+$177K	0.01%	1055
2018 Q3	$2.68M	Hold	40,730	–	–	0.01%	979
2018 Q2	$2.62M	Sell	40,730 -43,171	-51%	-$2.67M	0.01%	991
2018 Q1	$4.64M	Buy	83,901 +1,153	+1%	+$60.4K	0.01%	727
2017 Q4	$3.96M	Sell	82,748 -2,214	-3%	-$108K	0.01%	792
2017 Q3	$4.24M	Sell	84,962 -2,163	-2%	-$111K	0.01%	752
2017 Q2	$4.75M	Buy	87,125 +3,823	+5%	+$183K	0.01%	699
2017 Q1	$3.51M	Buy	83,302 +4,906	+6%	+$210K	0.01%	814
2016 Q4	$3.36M	Sell	78,396 -3,364	-4%	-$137K	0.01%	822
2016 Q3	$3.37M	Buy	81,760 +5,370	+7%	+$225K	0.01%	793
2016 Q2	$3.05M	Buy	76,390 +68,554	+875%	+$2.47M	0.01%	823
2016 Q1	$263K	Buy	7,836 +3,308	+73%	+$103K	﹤0.01%	1152
2015 Q4	$154K	Hold	4,528	–	–	﹤0.01%	1444
2015 Q3	$135K	Sell	4,528 -1,011	-18%	-$31.6K	﹤0.01%	1484
2015 Q2	$152K	Hold	5,539	–	–	﹤0.01%	1551
2015 Q1	$139K	Hold	5,539	–	–	﹤0.01%	1574
2014 Q4	$122K	Hold	5,539	–	–	﹤0.01%	1613
2014 Q3	$113K	Hold	5,539	–	–	﹤0.01%	1592
2014 Q2	$106K	Hold	5,539	–	–	﹤0.01%	1537
2014 Q1	$103K	Hold	5,539	–	–	﹤0.01%	1428
2013 Q4	$109K	Buy	+5,539	New	+$102K	﹤0.01%	1378

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Canada Life's IART Position: Q1 2026 in Review

Canada Life held its Integra LifeSciences (IART) position steady in Q1 2026 at 59,435 shares worth $560K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Canada Life first reported a position in IART in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.75M in Q2 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Canada Life held 59,435 shares of Integra LifeSciences worth $560K as of Q1 2026.
Canada Life left its Integra LifeSciences share count unchanged in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1483 holding.
Canada Life first reported a position in Integra LifeSciences in Q4 2013 and has held it in 49 quarters since.
Canada Life's Integra LifeSciences position peaked at $4.75M in Q2 2017.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.